Ciclesonide May Ease Sorafenib Resistance in Liver Cancer, Study Suggests
A CRISPR screening-informed five-gene signature identifies liver cancer patients with poor sorafenib response, and ciclesonide emerges as a candidate drug ...
A CRISPR screening-informed five-gene signature identifies liver cancer patients with poor sorafenib response, and ciclesonide emerges as a candidate drug ...
A retrospective study of 45 hepatocellular carcinoma patients found that intratumoral tertiary lymphoid structures were associated with disease control and ...
A meta-analysis of sixteen studies found that CT-defined sarcopenia was significantly associated with poorer overall survival, progression-free survival and tumor ...
TRIM29 promotes hepatocellular carcinoma growth by tagging the DAPK3 protein for proteasomal degradation, according to a new Cell Death Discovery ...
A 20-gene folate metabolism signature predicted hepatocellular carcinoma survival in some cohorts but failed in another, and the glutathione synthetase ...
A new study reports that the ubiquitin ligase substrate receptor DCAF13 promotes hepatocellular carcinoma progression by targeting RCAN1.4 for degradation ...
A six-gene T cell-derived signature built from single-cell transcriptomics stratified hepatocellular carcinoma patients by survival risk in two independent cohorts.
A new cell-culture study reports that an EGFR-IL-8 signaling loop between liver cancer cells and macrophages sustains lenvatinib resistance in ...
A new narrative review finds aflatoxins contaminate a quarter of global agricultural commodities, contribute to up to 28.2 percent of ...
A prospective study of 70 patients found that diffusion MRI metrics measured just outside liver tumors predicted microvascular invasion better ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine